Accelerate to discover

Homepage>Discover>Molecular imaging study design basics

Apr 5, 2024

Celloger live-cell analyzers, image and analyze your cells in real-time, inside your incubator. With its exceptional...

The chicken chorioallantoic membrane as a low-cost, high-throughput model for cancer imaging

Apr 4, 2024

Here, we assessed the chicken chorioallantoic membrane (CAM) as an alternative to mice for preclinical cancer imaging...

A microthrombus-driven fixed-point cleaved nanosystem for preventing post-thrombolysis recurrence

Apr 3, 2024

A thrombin-responsive and fixed-point cleaved Fu@pep-CLipo was developed for highly efficient and precise thrombolysis...

Webinar: Multimodal Assessment of Hypoxia in Tumors: From the Lab to the Clinic

Apr 2, 2024

25 April 2024, 4PM CET
This webinar will be of interest to multiple profiles in the community of biomedical
...

Apr 18, 2024

Multiplexed tissue imaging using the Orion platform to reveal the Spatial Biology of Cancer

Mar 27, 2024

In this webinar Prof. Sandro Santagata, will reveal how Orion high-plex imaging and the use of this data, is valuable...

A 19-color single-tube Full Spectrum Flow Cytometry for the detection of Acute Myeloid Leukemia

Mar 13, 2024

This recent publication in Cytometry Part A describes the development and comprehensive workflow of a single-tube,...

18F-labeled somatostatin analogs for somatostatin receptors (SSTRs) targeted PET imaging of NETs

Mar 11, 2024

A novel 18F-radiolabeled somatostatin analogue, [Al18F]NODA-MPAA-HTA, was synthesized and evaluated for positron...

Apr 18, 2024

Discover Yokogawa CellVoyager CQ1: Benchtop High-Content Analysis System

Mar 8, 2024

Unlike flow cytometers, the CellVoyager CQ1 confocal quantitative image cytometer does not require pretreatment such as...

Show all topics (10)

Molecular imaging study design basics

Jan 31, 2022

Mario A. Bourdon, PhD. has 30+ years of research experience in oncology, immunotherapeutics, molecular imaging and assay development. Mario received his PhD in Pathology from Duke University and served as CEO/CSO at the La Jolla Institute for Molecular Medicine prior to founding BioLaurus. BioLaurus offers In Vivo Preclinical Molecular Imaging consultancy and CRO services. By combining study design, study management, and image analytics in all major imaging modalities, BioLaurus has conducted critical preclinical and clinical stage drug development studies, primarily in the Safety Pharmacology space for large biotech and big pharma clients.

Watch the recoreded webinar and learn more!

Application

Video

Get more info